Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali
Clinical trial NCT03917654 · COMPLETED
Trial details
- NCT number
- NCT03917654
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-24
- Primary completion
- 2021-07-30
- Enrollment
- 1301
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.